Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

SIRT2 antibody

This Mouse Monoclonal antibody specifically detects SIRT2 in WB and ELISA. It exhibits reactivity toward Human.
Catalog No. ABIN1169092

Quick Overview for SIRT2 antibody (ABIN1169092)

Target

See all SIRT2 Antibodies
SIRT2 (Sirtuin 2 (SIRT2))

Reactivity

  • 75
  • 58
  • 51
  • 8
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Host

  • 76
  • 10
  • 1
Mouse

Clonality

  • 66
  • 21
Monoclonal

Conjugate

  • 50
  • 9
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This SIRT2 antibody is un-conjugated

Application

  • 56
  • 18
  • 17
  • 16
  • 15
  • 12
  • 11
  • 10
  • 3
  • 2
  • 2
  • 2
  • 1
Western Blotting (WB), ELISA

Clone

S2R233-1
  • Specificity

    Recognizes human sirtuin 2. Detects a band of ~45 kDa by Western blot.

    Cross-Reactivity

    Human

    Sterility

    0.2 μm filtered

    Immunogen

    Recombinant human sirtuin 2.

    Isotype

    IgG2b
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    Lot specific

    Buffer

    0.2μm-filtered solution in PBS, pH 7.4. Contains no preservatives.

    Preservative

    Without preservative

    Storage

    4 °C,-20 °C

    Storage Comment

    Short Term Storage: +4°C
    Long Term Storage: -20°C
    Stable for at least 1 year after receipt when stored at -20°C.

    Expiry Date

    12 months
  • Target

    SIRT2 (Sirtuin 2 (SIRT2))

    Alternative Name

    Sirtuin 2

    Background

    Sirtuin-2 is a NAD-dependent protein deacetylase, which deacetylates the 'Lys-40' of a-tubulin. It is involved in the control of mitotic exit in the cell cycle. Furthermore, a variety of age-associated diseases such as type 2 diabetes, obesity, osteoporosis, and Alzheimer's disease are associated with sirtuins. Selective inhibition of Sirtuin-2 achieves neuroprotection and identifies Sirtuin-2 to be a potential therapeutic avenue in Huntington's and Parkinson's disease.

    UniProt

    Q8IXJ6
You are here:
Chat with us!